Sarepta Therapeutics (SRPT) Construction in Progress (2013)
Sarepta Therapeutics' (SRPT) quarterly Construction in Progress came in at $11.3 million in Q4 2013.
Sarepta Therapeutics (SRPT) Construction in Progress (2013) Analysis & Trends
Sarepta Therapeutics' Construction in Progress history runs 1 years deep, the most recent figure standing at $11.3 million for Q4 2013.
- On a quarterly basis, Construction in Progress changed N/A year-over-year to $11.3 million in Q4 2013; TTM through Dec 2013 was $11.3 million, a N/A change from a year earlier, with the FY2013 full-year figure at $11.3 million, changed N/A from the prior year.
- Construction in Progress was little changed at $11.3 million in Q4 2013 per SRPT's latest filing.
- Across five years, Construction in Progress topped out at $11.3 million in Q4 2013 and bottomed at $11.3 million in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 137.45 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Sarepta Therapeutics | 1.66 Bn | 1.25 Bn | 622.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 11.30 Mn |